PCRX Share Price

Open 47.40 Change Price %
High 47.55 1 Day -1.00 -2.11
Low 46.25 1 Week -0.45 -0.96
Close 46.45 1 Month 1.30 2.88
Volume 374126 1 Year 7.57 19.47
52 Week High 58.95
52 Week Low 29.95
PCRX Important Levels
Resistance 2 47.66
Resistance 1 47.16
Pivot 46.75
Support 1 45.74
Support 2 45.24
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.22 0.00%
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
QQQ 138.03 -1.81%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SMSI 1.62 24.62%
CGEI 0.22 22.22%
THTI 0.20 17.65%
MYRX 0.07 16.67%
BDMS 13.50 16.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)

PCRX Technical Analysis 3
As on 27th Jun 2017 PCRX Share Price closed @ 46.45 and we RECOMMEND Buy for LONG-TERM with Stoploss of 40.73 & Buy for SHORT-TERM with Stoploss of 46.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
PCRX Target for June
1st Target up-side 49.04
2nd Target up-side 52.29
3rd Target up-side 55.54
1st Target down-side 39.76
2nd Target down-side 36.51
3rd Target down-side 33.26
PCRX Other Details
Segment EQ
Market Capital 512069248.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pacira.com
PCRX Address
PCRX
5 Sylvan Way
Suite 100
Parsippany, NJ 07054
United States
Phone: 973-254-3560
PCRX Latest News
Interactive Technical Analysis Chart Pacira Pharmaceuticals, Inc. ( PCRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacira Pharmaceuticals, Inc.
PCRX Business Profile
Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.